senicapoc has been researched along with norfluoxetine in 1 studies
| Studies (senicapoc) | Trials (senicapoc) | Recent Studies (post-2010) (senicapoc) | Studies (norfluoxetine) | Trials (norfluoxetine) | Recent Studies (post-2010) (norfluoxetine) |
|---|---|---|---|---|---|
| 42 | 3 | 32 | 275 | 33 | 69 |
| Protein | Taxonomy | senicapoc (IC50) | norfluoxetine (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 9 | |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily C member 1 | Rattus norvegicus (Norway rat) | 0.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.2909 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagal, SK; Brown, AD; Cox, PJ; Omoto, K; Owen, RM; Pryde, DC; Sidders, B; Skerratt, SE; Stevens, EB; Storer, RI; Swain, NA | 1 |
1 review(s) available for senicapoc and norfluoxetine
| Article | Year |
|---|---|
Ion channels as therapeutic targets: a drug discovery perspective.
Topics: Drug Discovery; Humans; Ion Channels; Models, Molecular; Phylogeny | 2013 |